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Abstract In Npc1 null mice, a model for Niemann Pick
Disease Type C1, it has been reported that hepatocyte insulin
receptor function is significantly impaired, consistent with
growing evidence that membrane fluidity and microdomain
structure have an important role in insulin signal transduction.
However, whether insulin receptor function is also compro-
mised in human Niemann Pick disease Type C1 is unclear. We
now report a girl who developed progressive dementia, ataxia
and opthalmoplegia from 9 years old, followed by severe
acanthosis nigricans, hirsutism and acne at 11 years old. She
was diagnosed with Niemann Pick Disease type C1
(OMIM#257220) based on positive filipin staining and
reduced cholesterol-esterifying activity in dermal fibroblasts,
and homozygosity for the p.Ile1061Thr NPC1 mutation.
Further analysis revealed her also to be heterozygous for a
novel trinucleotide deletion (c.3659+1_3659+3delGTG) at
the end of exon 20 of INSR, encoding the insulin receptor,
leading to deletion of Trp1193 in the intracellular tyrosine
kinase domain. INSR mRNA and protein levels were normal
in dermal fibroblasts, consistent with a primary signal
transduction defect in the mutant receptor. Although the
proband was significantly more insulin resistant than her
father, who carried the INSR mutation but was only
heterozygous for the NPC1 variant, their respective degrees
of IR were very similar to those previously reported in a
father–daughter pair with the closely related p.Trp1193Leu
INSR mutation. This suggests that loss of NPC1 function,
with attendant changes in membrane cholesterol composi-
tion, does not significantly modify the IR phenotype, even in




Insulin resistance (IR) and its clinical sequelae, including
type 2 diabetes, atherosclerosis and polycystic ovary
syndrome, are now at pandemic levels(Zimmet et al.
2001), and yet the precise molecular pathogenesis of
defective insulin action in the prevalent form of the
condition remains unclear. One strategy for gaining
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mechanistic insights into insulin action in vivo is to identify
and physiologically characterise naturally-occurring genetic
defects resulting in extreme forms of IR (O'Rahilly 2007).
The commonest Mendelian forms of primary IR are
accounted for by mutations in the gene encoding the insulin
receptor, INSR. At the most severe end of the spectrum,
biallelic mutations lead to autosomal recessive Donohue and
Rabson Mendenhall syndromes (Taylor et al. 1992). How-
ever heterozygous mutations in the tyrosine kinase domain
of the insulin receptor are more common, and produce
autosomal dominant severe IR that presents peripubertally in
females with acanthosis nigricans, hyperandrogenism and
ovulatory dysfunction, often with hyperglycaemia (Musso et
al. 2004). More than 100 loss-of-function alleles have now
been described, and a comprehensive mechanistic classifica-
tion of the defects has been established (Taylor et al. 1992).
However, insulin action depends upon more than just
integrity of each of the components of the signalling
pathway: correct spatial organisation of the insulin receptor
and its downstream signal transducers is also critical, and it
is now well established that insulin receptors are clustered
in specific microdomains of the plasma membrane, or lipid
rafts, defined in part by local membrane lipid composition
(Yaqoob 2009). A corollary of this is that pathological
alterations in membrane lipid composition and fluidity may
perturb insulin receptor function, and may contribute to
prevalent IR. Indeed, impaired insulin action has been
described in Gaucher disease, attributed to pathological
accumulation of GM3 gangliosides in the plasma
membrane (Langeveld et al. 2008a, b). Recently cell
autonomous IR has also been described in hepatocytes of
Balb/C mice with naturally occurring disruption of the
Npc1 gene due to an inserted retroposon, a genetic model of
Niemann Pick disease type C1. In these mice, cholesterol
accumulation in the plasma membrane perturbs membrane
fluidity and impairs signalling by hepatic insulin receptors
(Vainio et al. 2005), which would be expected to lead to
systemic IR. However, whether this phenomenon is also
operative in humans with NPC1 defects is not known. We
now describe a patient with Niemann Pick disease type C1
who co-inherited a novel heterozygous mutation in the tyrosine
kinase domain of the insulin receptor. Her degree of IR was
approximately commensurate with that previously reported in a
patient with a mutation of the same amino acid residue in the
insulin receptor, suggesting that any additional effect of the
NPC1 defect on insulin receptor signalling is mild at most.
Materials and methods
NPC1 mutation detection, filipin staining and cholesterol
esterification assays were undertaken by Dr M. Vanier at
the Centre Hospitalier Lyon-Sud using previously pub-
lished protocols (Chikh et al. 2004; Millat et al. 2005).
Insulin, leptin, and adiponectin were assayed using cus-
tomised autoDELFIA assays as previously described
(Semple et al. 2006).
Genetic study of the insulin receptor gene was undertaken
with full informed consent in line with procedures approved
by the local research ethics committee in Cambridge, U.K.
Genomic DNA was extracted from peripheral blood leuko-
cytes before PCR amplification of all 22 exons of the INSR
plus 50 bp of flanking sequence at either end of the exons
using 22 pairs of primers that had been designed in-house
using ExonPrimer via the USC genome browser (http://
genome.ucsc.edu/) and checked for common polymorphisms
using the NGRL Manchester program (http://ngrl.man.ac.uk/
SNPCheck/SNPCheck.html). The PCR products were puri-
fied using Agencourt® CleanSEQ® reagents (Agencourt
Bioscience, Beverly, MA, USA) and sequenced in both
directions using the BigDye® Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, PerkinElmer, Foster
City, CA, USA) and an ABI 3730 DNA sequencer (Applied
Biosystems). Sequence analysis was performed using Soft-
genetics® Mutation Surveyor™ (State College, PA, USA).
Dermal fibroblasts were maintained in Dulbecco’s
Modification of Eagle’s Medium supplemented with 10%
foetal calf serum, 2 mmol/l glutamine and penicillin/
streptomycin (all from Sigma Aldrich, St Louis, MO).
Cells were washed with phosphate-buffered saline before
harvest. RNA was extracted from cells using the RNEasy
kit (Qiagen) according to manufacturer’s instructions, and
1 μg of extracted, purified RNA was reverse transcribed in
a total volume of 50 μl using 400 ng Random Primers,
400U Reverse Transcriptase and 0.5 mM dNTPs (all from
Promega, Madison, WI). cDNA was sequenced as de-
scribed for genomic DNA but using cDNA as template.
INSR mRNAwas quantified using custom designed probes
and primers (Probe: 5′ FAM-AGGCTGTGGTGCTGA
TG-TAMRA-3′; F Primer: 5 ′-GCAGATCCGCATG
TCCCTT-3′; R Primer: 5′-TGTTTTCCAGGTGCCCTC
G-3′), Taqman Master Mix (Applied Biosystems) and an
Applied Biosystems 7300 real-time PCR analyser. Results
were normalised to expression of 36B4 for which custom
designed probes and primers were used (Probe: 5′
JOE-AGGCTGTGGTGCTGATG-TAMRA-3′; F Primer:
5 ′ -GCAGATCCGCATGTCCCTT-3 ′ ; R P r ime r :
5′-TGTTTTCCAGGTGCCCTCG-3′). For each gene, a stan-
dard curve was generated and used to determine relative gene
expression.
For protein studies, subconfluent fibroblasts were lysed
on ice in 500 µl of protein lysis buffer (50 mM Hepes,
150 mM NaCl, 30 mM NaF, 10 mM Na4P2O7, 1 mM
Na2VO4, 1% Triton X100, 10 mM EDTA, 0.5 mM PMSF)
before incubation on a rotary agitator platform for 30 min at
4°C and removal of cell debris by centrifugation at 12,000g
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for 15 min. The supernatant containing cellular protein was
transferred to a fresh microfuge tube, quantified and stored
at −80°C. Later, 400 μg of each lysate was incubated for
3 h at 4°C with an insulin receptor-specific monoclonal
antibody (83-14; a gift from Prof. Kenneth Siddle; Soos et
al. 1989) in a solution made up to 1 ml with immunopre-
cipitation buffer (50 mM Hepes, 150 mM NaCl, 30 mM
NaF, 10 mM Na4P2O7), followed by addition of 50 μl pre-
washed Protein A-agarose (Sigma Aldrich) and further
incubation for 1 h at 4°C. Beads were then washed using
wash buffer (immunoprecipitation buffer plus 10 mM
EDTA, 0.2% Triton X100 and protease inhibitors; Roche)
prior to washing and collection by centrifugation. Samples
were re-suspended in 30 μl 1.5×SDS loading buffer
(75 mM Tris-HCL pH6.8, 3% w/v SDS, 15% v/v glycerol,
0.00015% w/v bromophenol blue, 15 v/v β-ME) before
western blotting.
Western blot analysis of 15 µl of immunoprecipitate
used an 8% reducing polyacrylamide gel, followed by
transfer to an Immobilon-P transfer membrane (Millipore,
Billerica, MA). The membrane was probed with anti-total
Insulin Receptor β-chain antibody (SC-711; Santa Cruz
Biotech,).
Case History
The female proband presented at 9 years old with slurred
speech and mild gait unsteadiness, at which stage computed
tomography of her brain was unremarkable. She was born
at term at 2.76 kg to parents who were first cousins, and
early development was unremarkable. At 11 years old, she
developed acanthosis nigricans, widespread acne, hirsutism
and deepening of her voice. She had not yet experienced
menarche. Examination at 12 years old revealed a height of
159.8 cm (50th centile), weight 53.8 kg ( 75th centile) and
body mass index of 21 kg/m2 (+0.9SD). MRI imaging at
this stage showed increased signal intensity in the periven-
tricular white matter creating a hazy appearance which,
although often regarded as non-significant, we have
frequently observed in patients with Niemann Pick type
C1 disease (C. Hendriksz, unpublished observation). There
was prominent axillary acanthosis nigricans, Ferriman
Gallwey Grade 3 facial hirsutism, Tanner stage 4 pubic
hair, stage 3 axillary hair and stage 3 breast development.
There was mild cliteromegaly but otherwise unremarkable
genitalia. Investigation showed elevated serum testosterone
and androstenedione (at 4.8 nmol/l and 13.4 nmol/l,
respectively) with high levels of urinary androgen and
cortisol metabolites, but no excess intermediates to suggest
a biosynthetic defect. Her 17 hydroxyprogesterone was
normal (2.9 nmol/l). Abdominal ultrasonography showed
polycystic ovaries and a normal prepubertal uterus. Two
gallstones and heterogeneously increased hepatic echotex-
ture were incidentally noted. Oral glucose tolerance testing
showed impaired glucose tolerance with severe hyper-
insulinaemia (Table 1). A combined oral contraceptive
preparation containing cyproterone acetate (Dianette), oxy-
tetracycline and depilation were commenced and produced
considerable improvement in both acne and hirsutism;
however, metformin was not tolerated due to gastrointesti-
nal side effects. Despite this, a further oral glucose
tolerance test performed 2 years later showed normal
glucose tolerance.
Neurological examination at 12 years old was reported
to reveal myopathic facies with ptosis, some supranuclear
impairment of upgaze, and somewhat nasal and dysarthric
speech. There was a broad-based ataxic gait, pes cavus,
increased lumbar lordosis, and mild proximal leg weakness
with hyperreflexia. Blood chitotriosidase was elevated on
two occasions. Muscle biopsy showed minor non-specific
myopathic features, and moderate hypertrophy of type IIb
fibres. Filipin staining of cultured skin fibroblasts showed
massive accumulation of perinuclear vesicles, while cho-
lesterol ester formation in lipoprotein deficient serum was
grossly reduced at 30 pmol/4.5 hours/mg protein (5th–95th
centile for controls 550–5350). Sequencing of the NPC1






















II.15 F 70 24.3 4.7 73 6.5 – – –
III.1 F 38 26.9 4.9 74 5.5 – – –
III.2 M 40 25.6 4.9 349 7.1 7.1 (1.5–13.0) 3.9 Tg 0.9 HDL-C 0.83
IV.1 F 12 23.7 3.1 1096 10.0 21.8 (2.4–24.4) 10.6 Tg 0.4 HDL-C 1.02
IV.2 M 9 18.6 5.6 63 5.5 – – –
Normal range – – – 3.5–5.5 0–60 <7.8 – b Tg < 2.2 HDL-C >0.9
a Refers to time after 75 g oral glucose load
b In the context of severe insulin resistance, an adiponectin of >7 mg/l has a 97% positive predictive value for insulin receptoropathy
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gene (GenBank NM_000271) revealed homozygosity for
the p.Ile1061Thr mutation, the commonest pathogenic
mutation in Europids (Millat et al. 1999).
Further sequencing of genomic DNA revealed heterozy-
gosity for the previously unreported deletion of one of a
pair of trinucleotides around the end of exon 20 of the INSR
gene (GenBank NM_000208; c.3659+1_3659+3delGTG)
(Fig. 1a). Sequencing of cDNA from dermal fibroblasts
confirmed heterozygous deletion of this trinuceotide also in
the cDNA (Fig. 1b), leading to deletion of the highly
conserved Tryptophan 1193 from the mature receptor





Fig. 1 The Proband has a heterozygous GTG deletion at the end of
exon 20 of the INSR gene in genomic DNA (a), which is seen also in
INSR cDNA (b). The nucleotide deletion causes deletion of Trp1220
(Trp1193 in the mature receptor), a strongly conserved residue (c)
located in an alpha helix within the tyrosine kinase damin of the
receptor. There was no detectable change in expression of the INSR in
dermal fibroblasts from the proband as assessed by quantitative real
time PCR (d) and immunoprecipitation/immunoblotting (e) for the
insulin receptor beta subunit
Fig. 2 Family tree of the pro-
band (arrowed) including NPC1
and INSR genotype and clinical
status. Black shading Niemann
Pick Disease Type C1, hatched
shading severe insulin resis-
tance. Where genotypes are not
given, they are unknown
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itation/immunoblotting showed no reduction in INSR
expression in dermal fibroblasts from the proband com-
pared to controls (Fig. 1d, e).
Fasting glucose and insulin were determined in the
proband’s parents and brother, each of whom were also
genotyped for the INSR and NPC1 mutations found in
the proband (Fig. 2). The father of the proband was a
double heterozygote for the NPC1 and INSR mutations,
while no other family member carried the INSR mutation.
He was also severely IR, but markedly less so than the
proband, as assessed by the level of fasting hyper-
insulinemia. The proband’s mother and 9-year-old brother
were well. However, although the brother had normal
levels of plasma insulin, he also had impaired fasting
glycaemia using the American Diabetes Association
International Society for Paediatric and Adolescent
Diabetes guidelines.
Discussion
The single tryptophan deletion (delTrp1293) described here
in the insulin receptor is novel, although a missense
mutation changing the same tryptophan to leucine
(Trp1293Leu) has previously been described and function-
ally characterised (Iwanishi et al. 1993). While the
Trp1293Leu species was reported to show severely im-
paired processing and cell surface expression,levels of the
mature beta subunit of the insulin receptor in dermal
fibroblasts from the proband with the heterozygous
delTrp1293 were, however, normal. This may be because
the loss of function of the delTrp1293 receptor is accounted
for purely by impaired signal transduction rather than loss
of its cell surface expression. A caveat to this interpretation
is, however, suggested by the observation in mice that loss
of Npc1 function leads to upregulation of cell surface Insr
expression (Vainio et al. 2005), which, if also operative in
human dermal fibroblasts, may mask an additional effect of
the novel delTrp1293 mutation on receptor processing. A
large body of literature has established that missense
mutations or deletions affecting the beta subunit of the
insulin receptor characteristically exert dominant negative
activity over co-expressed wild-type receptor. This is due to
a requirement for activity of both constituent monomers in
order for receptor autophosphorylation to occur in response
to insulin (Odawara et al. 1989; Whittaker et al. 1990). A
corollary of this is that, as long as processing and
membrane residency time of the mutant receptor is normal,
it is to be expected that only 25% of cell surface receptor
dimmers will be functional. This most commonly leads to
severe IR that presents around the time of puberty in girls,
which may be precocious, as hyperandrogenism, oligome-
norrhoea and acanthosis nigricans (Taylor et al. 1992).
There have been no reports of severe insulin
resistance in Niemann Pick disease type C1, nor any
cross-sectional studies of the range of insulin sensitivity
in this condition to permit a judgement to made about
the integrity of insulin receptor function. In this case, the
independent defect in the insulin receptor, likely to
reduce receptor function by around 75%, is enough to
cause severe IR on its own. However, it is also likely
to sensitize the patient to “second hits” at the level of the
receptor. For example, haploinsufficiency for the insulin
receptor does not produce severe IR in slim patients, but
produces extreme IR in the face of obesity. Thus, the
rare patient we describe serves as a robust test for an
impact of loss of NPC1 function on insulin receptor
function in vivo. At first sight, the greater IR in the
proband than in her father argues that this predicted
exacerbation of IR is being seen in this case. However,
this is confounded by the fact that IR is generally
expressed more severely in females and is also exacer-
bated by puberty. Indeed, the fasting insulin levels
reported here are very similar to those reported in the
father and daughter pair with the closely related
Trp1193Leu mutation, and are also in keeping with
levels in our cohort of patients with severe IR (Iwanishi
et al. 1993). We thus conclude that the effect of loss of
NPC1 function on insulin receptor signalling in humans in
vivo is likely to be mild at most. Nevertheless, more
detailed cross-sectional studies of insulin sensitivity in
Niemann Pick disease type C1 are warranted, and
clinicians should be alert to the clinical stigmata of IR,
including acanthosis nigricans, and oligomenorrhoea and
hyperandrogenism in girls.
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